Novel Molecular Regulators of Vascular Calcification
Novel Molecular Regulators of Vascular Calcification
批准号:
10605099
负责人:
Sujin Lee
金额:
$7.82万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2025-06-30
关键词:
AortaArylsulfatasesAtherosclerosisAutomobile DrivingBioinformaticsBiological AssayBiologyBlood VesselsBone DevelopmentBone Morphogenetic ProteinsCardiovascular DiseasesCell physiologyCellsCellular AssayCodeCohort StudiesCommunicationCoronaryCoronary ArteriosclerosisCoronary arteryCultured CellsCytosolDataDiseaseEstersEventExperimental ModelsFamilyFellowshipFocal Adhesion Kinase 1FundingGenesGenomicsGoalsHDAC4 geneHDAC5 geneHDAC9 geneHistone DeacetylaseIn VitroIndividualKnockout MiceLaboratoriesLeadershipMediatingMentorshipMethodsModelingMolecularMorbidity - disease rateMyocardial InfarctionNuclearOsteogenesisPathogenesisPathologyPeripheral arterial diseasePhenotypePhosphorylationPlayPreventionProcessProtein FamilyProteinsRegulationResearchRisk FactorsRoleScientistSignal PathwaySignaling ProteinSingle Nucleotide PolymorphismSmall Interfering RNASmooth Muscle MyocytesStrokeSulfatasesSulfateSurgeonTestingUnited States National Institutes of HealthVariantVascular DiseasesVascular Smooth MuscleVascular calcificationX Chromosomeabdominal aortaadenoviral mediatedcalcificationcardiovascular risk factorcareercartilage developmentcoronary artery calcificationexperimental studygenome wide association studygenome-widein vivoinhibitorinsightkinase inhibitorknock-downmRNA Expressionmembermortalitymouse modelnew therapeutic targetnovelosteogenicoverexpressionpharmacologicpreventprogramsskillstargeted treatmenttranscription factor
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Atherosclerotic disease is characterized by intimal vascular calcification, which is an
independent and potent risk factor for morbidity and mortality in coronary artery disease, stroke,
and aortic pathologies. Vascular calcification is an active cell-mediated process that involves the
phenotypic switch of vascular smooth muscle cells (VSMC) from contractile to osteogenic cells.
Understanding the molecular mechanisms driving vascular calcification is critical for developing
targeted therapies. In our lab, we have identified novel single nucleotide polymorphisms (SNPs)
in the arylsulfatase E (ARSE) locus on the X chromosome that are associated with coronary
artery calcification. Our preliminary data demonstrate that adenovirus-mediated overexpression
of ARSE in VSMCs leads to increased calcification and that conversely, reduced expression of
ARSE with siRNA prevents calcification of VSMCs. We have identified SULF1, a protein related
to ARSE in the same family of sulfatases, as having similar effects on vascular calcification as
that demonstrated in our in vitro studies for ARSE. Based on our previous studies, we have also
identified histone deacetylase 4 and 5 (HDAC4/5) to be important regulators of vascular
calcification, mediated by subcellular localization of HDAC4/5 in the cytosol through
phosphorylation by focal adhesion kinase (FAK). The goal of this project is to perform in vitro, ex
vivo, and in vivo studies to test the hypothesis that ARSE/SULF1 and HDAC4/5 are important
and novel determinants of vascular calcification that induce the phenotypic switch of VSMCs to
osteogenic cells. Overall, my aim is to unravel novel molecular mechanisms underlying VSMC
function and calcification that contribute to the pathogenesis of atherosclerotic cardiovascular
disease. Through world-class didactic opportunities and close mentorship from experts in the
field of vascular biology and genomics, I will complete this project having gained valuable skills
in bioinformatics, in vitro cellular assays modeling vascular disease, in vivo mouse model
experiments, scientific communication and laboratory leadership. By the end of the fellowship, I
will have gained skills necessary to develop my own research program and ultimately launch my
own career as an NIH-funded vascular surgeon scientist.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文